Similarly, nesfatin-1 enhances proliferation and migration in the endometrial carcinoma cell line Ishikawa, while NUCB2 knockdown via siRNA impairs these processes (Takagi et al. 2016). This evidence concerns the gene NUCB2 and endometrial carcinoma.